Cargando…

The gut microbiome and its interaction with health, disease, treatment response and toxicity in patients advanced cancer: focus on lung cancer and immunotherapy

Detalles Bibliográficos
Autores principales:	Tinsley, Nadina, Cook, Natalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815345/ https://www.ncbi.nlm.nih.gov/pubmed/33489792 http://dx.doi.org/10.21037/tlcr-20-407

Ejemplares similares

Gut Microbiome and the Response to Immunotherapy in Cancer
por: Stancu, Andreea Lucia
Publicado: (2018)

Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer
por: Grenda, Anna, et al.
Publicado: (2022)

Oral–Gut Microbiome Crosstalk in Cancer
por: Inamura, Kentaro
Publicado: (2023)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
por: Oh, Byeongsang, et al.
Publicado: (2021)

Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome
por: Camara-Lemarroy, Carlos R, et al.
Publicado: (2018)

Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy
por: Young, M. Rita I.
Publicado: (2017)

Recent advances in cancer immunotherapy
por: Sun, Weijing
Publicado: (2017)

Recent Advances in Cancer Immunotherapy
por: Suda, Kenichi
Publicado: (2021)

Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
por: Singh, Ankita, et al.
Publicado: (2023)

Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
por: Liu, Ben, et al.
Publicado: (2022)

Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2022)

The Microbiome and Its Implications in Cancer Immunotherapy
por: Choudhry, Hani
Publicado: (2021)

Deciphering the impacts of gut and tissue microbiome on human cancers
por: Godbole, Mukul S., et al.
Publicado: (2023)

Advances in cancer immunotherapy for gastroenterological malignancy
por: Kono, Koji
Publicado: (2018)

Drugs and gut microbiome interactions—an emerging field of tailored medicine
por: Khan, Imran
Publicado: (2023)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
por: Temraz, Sally, et al.
Publicado: (2019)

The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer
por: Sillo, Toritseju O., et al.
Publicado: (2023)

Lung cancer treatment in the era of immunotherapy
por: Xu, Yang, et al.
Publicado: (2020)

Dysbiosis of the Gut Microbiome in Lung Cancer
por: Zhuang, He, et al.
Publicado: (2019)

Advancing cancer immunotherapy: a vision for the field
por: de Miranda, Noel F. C. C., et al.
Publicado: (2019)

Molecular Basis and Advances in Targeted Immunotherapy for Cancer
por: Macciò, Antonio, et al.
Publicado: (2023)

Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations
por: Wardill, Hannah R., et al.
Publicado: (2022)

Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
por: Hirata, Tsuyoshi, et al.
Publicado: (2023)

Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer
por: Van Dingenen, Lena, et al.
Publicado: (2023)

Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
por: Shui, Lin, et al.
Publicado: (2020)

The Role of the Gut Microbiome in Cancer Immunotherapy: Current Knowledge and Future Directions
por: Kiousi, Despoina E., et al.
Publicado: (2023)

Toxicities of Immunotherapy for Small Cell Lung Cancer
por: Fu, Yang, et al.
Publicado: (2021)

Gut Microbiome Toxicity: Connecting the Environment and Gut Microbiome-Associated Diseases
por: Tu, Pengcheng, et al.
Publicado: (2020)

Gut microbiome and psychiatric disorders
por: Afroz, Kazi Farhana, et al.
Publicado: (2023)

Gut peptides and the microbiome: focus on ghrelin
por: Leeuwendaal, Natasha K., et al.
Publicado: (2021)

Gut microbiome and its role in colorectal cancer
por: Rebersek, Martina
Publicado: (2021)

The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer
por: Duttagupta, Sreya, et al.
Publicado: (2023)

Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications
por: Zhao, Xianda, et al.
Publicado: (2023)

Advances in lung cancer
por: Pacheco, Jose M., et al.
Publicado: (2017)

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
por: Zhang, Mengwei, et al.
Publicado: (2023)

Cardiopulmonary Pathogenic Networks: Unveiling the Gut–Lung Microbiome Axis in Pulmonary Arterial Hypertension
por: Oliveira, Suellen Darc
Publicado: (2022)

Cross communication of diet-microbiome-immune interactions in cancer immunotherapy
por: Zhou, Cheng-Bei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2e0cvv4q47nbs9040ur1h1h4g4